This study by Goods and colleagues also showed that the percentage of TIM-3 positivity on infiltrating CD4+ T cells was significantly higher than that on peripheral CD4+ T cells in glioblastoma patients. The gene discussed is HAVCR2; the disease is glioblastoma.